期刊文献+

2005—2014年天津市宝坻区疑似预防接种异常反应监测结果分析 被引量:6

Analysis on surveillance results of suspected adverse events following immunization in Baodi District of Tianjin from 2005-2014
原文传递
导出
摘要 目的分析天津市宝坻区疑似预防接种异常反应(AEFI)发生特征,评价疫苗接种安全性及AEFI监测系统运行情况。方法收集2005—2014年9月宝坻区疾病预防控制中心登记在册的AEFI个案资料,从我国《疑似AEFI信息管理系统》下载宝坻区报告的AEFI信息,采用描述流行病学方法进行分析。结果 2005—2014年9月宝坻区共报告AEFI个案416例,累计报告发生率为6.61/10万剂;其中一般反应318例,占76.44%;异常反应93例,占22.36%;偶合症4例,占0.96%;心因性反应1例。无接种事故报告。结论宝坻区AEFI监测系统运转正常,所使用的疫苗安全性和预防接种服务质量良好。 [Objective]To analyze the characteristics of suspected adverse events following immunization (AEFI) cases in Baodi District of Tianjin, evaluate the safety of vaccination and operation status of AEFI monitoring system.[Methods]The data of AEFI cases registered in Baodi District Center for Disease Control and Prevention from September 2005 to September 2014, and AEFI information in Baodi District collected from China suspected AEFI information management system were analyzed by the descriptive epidemiologieal method.[Results]A total of 416 AEFI cases were reported in Baodi District from September 2005 to September 2014, and the cumulative report incidence rate was 6.61/100 000 dose. 318 (76.44%) cases were common reactions, 93 (22.36%) cases were abnormal reactions, 4 (0.96%) cases were coincidental events, and 1 case was psychogenic reaction. There was no vaccination accident.[Conclusion]AEFI surveillance system runs well in Baodi District, while the safety of vaccine and quality of vaccination service are satisfactory.
作者 张秀梅 谷超
出处 《职业与健康》 CAS 2015年第15期2128-2130,共3页 Occupation and Health
关键词 预防接种异常反应 监测 疫苗 Adverse Events Following Immunization (AEFI) Surveillance Vaccine
  • 相关文献

参考文献8

二级参考文献39

  • 1刘大卫.如何开展预防接种异常反应监测工作[J].中国计划免疫,2006,12(4):322-327. 被引量:65
  • 2卫生部.预防接种异常反应鉴定办法[S].2008.
  • 3卫生部办公厅,国家食品药品监督管理局办公室.全国疑似预防接种异常反应监测方案[S].2010-06-03.
  • 4昊建宏 陈浩 董国萍 等.绍兴市2009年疑似预防接种异常反应监测结果.浙江预防医学,2010,26(15):35-40.
  • 5卫生部.预防接种工作规范[S].2005.
  • 6国务院.疫苗流通和预防接种管理条例[S].2005-03.
  • 7Kari SL, Satu P, Terhi K, et al. Vaeeinovigilanee in Europe-need for timeliness, standardization and resources [J]. Bull WHO, 2004, 82 ( 11 ) :828-835.
  • 8Collet JP, MacDonald N, Cashman, et al. Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee[J]. Bull WHO, 2000, 78 (2) :178-185.
  • 9卫生部办公厅.疫苗相关麻痹型脊髓灰质炎病例诊断依据及涪疗参考意见[S].2008-02-04.
  • 10卫生部办公厅.过敏性紫癜等6种疾病诊疗指南[S].2010-09-23.

共引文献370

同被引文献45

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部